What's New at the Premier RNA Drug Discovery Summit?
As RNA-targeting small molecules move toward therapeutic validation, the field is reaching a point where target selection, selectivity and translational confidence are critical. The 9th RNA-Targeted Drug Discovery & Development Summit will showcase key advances across splice modulation, RNA degradation, direct binding, translation inhibition, epitranscriptomics and induced-proximity strategies.
The agenda tracks progress from RNA modulation and AI-driven structure prediction through screening, design and validation. With case studies across oncology, rare neurological disease and neurodegeneration, attendees will gain a clear view of which approaches are ready to move into developable, clinically relevant programs.
The summit also brings together experts across RNA biology, chemistry and drug development. It offers a space to connect, validate targets and strengthen the evidence needed to move RNA-targeted small molecules toward real therapeutic impact.
New Companies For 2026 Include
Showcase Your Scientific Poster This Year
Demonstrate your thought leadership and engage in meaningful conversations with industry peers. This session is designed to help you connect with RNA biologists, medicinal chemists, drug discovery leaders, structural biologists, computational scientists, and translational experts in a relaxed setting while forging valuable new relationships.
When is the Scientific Poster Session? It will be held on Wednesday, November 11 at 2:30pm (Conference Day 1).
How to Submit Your Poster
First Register Your Place To Attend
Submit an abstract for review to showcase your poster during the Scientific Poster Session
You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit.
What Are Key Sessions You Shouldn't Miss?
Exploring How Chemically Diverse Fragments Target a Cryptic RNA Binding Pocket through Base Displacement
Advancing Oral Splice-Modulating Small Molecules Toward Clinical Development for Rare Neurodegenerative Diseases
Optimization & Functional Characterization of MYC RNA-Targeting Small Molecules
Rational, Structure-Guided Design of Small Molecule Covalent Translation Inhibitors Targeting mRNA
Modelling Approaches to Understand RNA Structure, Dynamics, & Small Molecule Binding to Guide Target Selection & Improve Small Molecule Design
Explore the Agenda
Hear the latest industry advances in RNA target selection, structure-guided design, selective modulation and translational strategies across the full RNA-targeted small molecule pipeline and during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Connect with RNA-targeted small molecule leaders across discovery, preclinical and clinical development during our dedicated networking sessions to exchange insights, build collaborations and strengthen decisions from target selection to therapeutic impact.